Risk Management in Blood Transfusion: The Virtue of Reality

I. Perception of Risk.- Does Perceived Risk Withhold People from Donating Blood?.- Managing Risks from an Insurer’s Perspective.- Bad Blood or the Elixir of Life? Perceived Risk of Blood Transfusions.- The Role of Cost-Effectiveness Analysis in Defining Transfusion Medicine Policy.- II. Management of Infection Defined Risks.- Risks of Transfusion-Transmitted Infection: A Comparative Analysis of Then and Now.- Prevention of Transfusion Transmissible Infections: The Impact of the Recent Past on Current Decision Making.- Management of Infection-Defined Risks.- Closing the Window of Early HIV Infection by Incorporation of HIV p24 Ag Detection.- GAT Testing: Added Value?.- III. Management of Immune Defined Risks.- The Role of T and B Cells in Transfusion-Related Immune Reactions: Cytokines and the Removal of Apoptotic Material.- Involvement of B-cells in Peripheral Scrapie Pathogenesis.- Alternative Approaches to Prevention of Alloimmunisation: A Virtue of Reality?.- Transfusion-Associated Immunodulation in Cancer Recurrence and Postoperative Infection: Meta-Analyses of Randomised Controlled Trials.- Does General Leukodepletion Provide Any Better Outcome?.- IV. Risk Management in Clinical Practice: Optimal vs Maximal.- Haemovigilance: An Approach to Risk Management and Control.- Evidence-Based Transfusion Medicine: A Fundamental Part of Risk Management.- Safety and Supply Issues from Consumers Point of View.- The Value of Education to Improve Perception, Acceptance and Communication of Transfusion-Related Risk.- This is the Bloody Limit.- The Virtue of Reality: Global Strategies in the Management of Transfusion-Related Risks.